Compare MSEX & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MSEX | INMD |
|---|---|---|
| Founded | 1897 | 2008 |
| Country | United States | Israel |
| Employees | 395 | N/A |
| Industry | Water Supply | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 984.5M | 842.0M |
| IPO Year | N/A | 2018 |
| Metric | MSEX | INMD |
|---|---|---|
| Price | $57.66 | $14.81 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 5 |
| Target Price | ★ $61.33 | $17.33 |
| AVG Volume (30 Days) | 153.9K | ★ 741.8K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.77% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.60 | $1.74 |
| Revenue Next Year | $10.94 | $3.26 |
| P/E Ratio | $22.68 | ★ $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $44.94 | $12.72 |
| 52 Week High | $62.18 | $16.74 |
| Indicator | MSEX | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 73.53 | 67.22 |
| Support Level | $49.91 | $14.58 |
| Resistance Level | $62.18 | $15.23 |
| Average True Range (ATR) | 1.20 | 0.27 |
| MACD | 0.47 | 0.14 |
| Stochastic Oscillator | 93.28 | 81.82 |
Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.